Literature DB >> 10885608

Natural history of untreated head and neck cancer.

L P Kowalski1, A L Carvalho.   

Abstract

This paper describes the characteristics and natural history of the largest reported group of patients with untreated head and neck cancer. From 1953 to 1990, 808 untreated head and neck cancer patients were followed-up until their death. All patients were given supportive care, but specific oncological treatment was not pursued secondary to advanced tumour stage, poor performance status and/or patients' refusal of any treatment. The overall survival ranged from 1 day to 53.8 months (median 3.82 months). Performance status was the most significant predictor of survival (P < 0.001). A subgroup of 357 patients with good performance status and aged less than 70 years old had a 12.9% 1-year survival. Approximately 50% of untreated head and neck cancer patients will die within 4 months of their diagnosis. However, the remaining patients can survive up to 4 or more years, depending on their tumour location, extent, performance status and level of supportive care.

Entities:  

Mesh:

Year:  2000        PMID: 10885608     DOI: 10.1016/s0959-8049(00)00054-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  42 in total

Review 1.  Gene therapy in head and neck cancer: a review.

Authors:  E Chisholm; U Bapat; C Chisholm; G Alusi; G Vassaux
Journal:  Postgrad Med J       Date:  2007-12       Impact factor: 2.401

2.  Outcomes of salvage surgery for the oropharynx and larynx: a contemporary experience in a UK Cancer Centre.

Authors:  Ashley Hay; Ricard Simo; Gillian Hall; Selvam Tharavai; Richard Oakley; Alastair Fry; Luke Cascarini; Mary Lei; Teresa Guerro-Urbano; Jean-Pierre Jeannon
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-21       Impact factor: 2.503

3.  Untreated head and neck cancer in Korea: a national cohort study.

Authors:  Hyo Geun Choi; Bumjung Park; Soon-Hyun Ahn
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-14       Impact factor: 2.503

Review 4.  Circulating miR-21 as a Potential Biomarker for the Diagnosis of Oral Cancer: A Systematic Review with Meta-Analysis.

Authors:  Mario Dioguardi; Giorgia Apollonia Caloro; Luigi Laino; Mario Alovisi; Diego Sovereto; Vito Crincoli; Riccardo Aiuto; Erminia Coccia; Giuseppe Troiano; Lorenzo Lo Muzio
Journal:  Cancers (Basel)       Date:  2020-04-10       Impact factor: 6.639

Review 5.  Essentials of oral cancer.

Authors:  César Rivera
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 6.  Causes of death of patients with laryngeal cancer.

Authors:  Alfio Ferlito; Missak Haigentz; Patrick J Bradley; Carlos Suárez; Primož Strojan; Gregory T Wolf; Kerry D Olsen; William M Mendenhall; Vanni Mondin; Juan P Rodrigo; Carsten C Boedeker; Marc Hamoir; Dana M Hartl; Jennifer L Hunt; Kenneth O Devaney; Lester D R Thompson; Alessandra Rinaldo; Robert P Takes
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-17       Impact factor: 2.503

7.  Survival outcomes in elderly patients with untreated upper aerodigestive tract cancer.

Authors:  Brian B Hughley; Steven M Sperry; Timothy A Thomsen; Mary E Charlton; Nitin A Pagedar
Journal:  Head Neck       Date:  2016-08-10       Impact factor: 3.147

8.  FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma.

Authors:  Vasavi Paidpally; Alin Chirindel; Christine H Chung; Jeremy Richmon; Wayne Koch; Harry Quon; Rathan M Subramaniam
Journal:  AJR Am J Roentgenol       Date:  2014-08       Impact factor: 3.959

9.  Phase II study of sunitinib malate in head and neck squamous cell carcinoma.

Authors:  Nicholas W Choong; Mark Kozloff; David Taber; H Shawn Hu; James Wade; Percy Ivy; Theodore G Karrison; Allison Dekker; Everett E Vokes; Ezra E W Cohen
Journal:  Invest New Drugs       Date:  2009-08-04       Impact factor: 3.850

10.  Efficacy and safety of photodynamic therapy with temoporfin in curative treatment of recurrent carcinoma of the oral cavity and oropharynx.

Authors:  M Durbec; A Cosmidis; C Fuchsmann; A Ramade; P Céruse
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-29       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.